Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
7,446,842
-
Share change
-
+7,446,842
-
Total reported value
-
$68,363,000
-
Price per share
-
$9.18
-
Number of holders
-
17
-
Value change
-
+$68,363,000
-
Number of buys
-
17
Institutional Holders of BELLEROPHON THERAPEUTICS INC - COM (BLPH) as of Q1 2015
As of 31 Mar 2015,
BELLEROPHON THERAPEUTICS INC - COM (BLPH) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,446,842 shares.
The largest 10 holders included
KLINSKY STEVEN B, FMR LLC, Senator Investment Group LP, BAKER BROS. ADVISORS LP, HIGHLAND CAPITAL MANAGEMENT LP, Catalyst Capital Advisors LLC, Alyeska Investment Group, L.P., SABBY MANAGEMENT, LLC, MORGAN STANLEY, and GOLDMAN SACHS GROUP INC.
This page lists
17
institutional shareholders reporting positions in this security
for the Q1 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.